1. Home
  2. BDRX vs FRES Comparison

BDRX vs FRES Comparison

Compare BDRX & FRES Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BDRX
  • FRES
  • Stock Information
  • Founded
  • BDRX 2000
  • FRES 2010
  • Country
  • BDRX United Kingdom
  • FRES United States
  • Employees
  • BDRX N/A
  • FRES N/A
  • Industry
  • BDRX Biotechnology: Pharmaceutical Preparations
  • FRES Medical Specialities
  • Sector
  • BDRX Health Care
  • FRES Health Care
  • Exchange
  • BDRX Nasdaq
  • FRES Nasdaq
  • Market Cap
  • BDRX 9.6M
  • FRES 6.4M
  • IPO Year
  • BDRX N/A
  • FRES 2020
  • Fundamental
  • Price
  • BDRX $0.79
  • FRES $2.22
  • Analyst Decision
  • BDRX Strong Buy
  • FRES
  • Analyst Count
  • BDRX 1
  • FRES 0
  • Target Price
  • BDRX $8.00
  • FRES N/A
  • AVG Volume (30 Days)
  • BDRX 4.2M
  • FRES 12.6K
  • Earning Date
  • BDRX 04-19-2024
  • FRES 09-17-2024
  • Dividend Yield
  • BDRX N/A
  • FRES N/A
  • EPS Growth
  • BDRX N/A
  • FRES N/A
  • EPS
  • BDRX N/A
  • FRES N/A
  • Revenue
  • BDRX $482,278.00
  • FRES $2,345,304.00
  • Revenue This Year
  • BDRX N/A
  • FRES N/A
  • Revenue Next Year
  • BDRX N/A
  • FRES N/A
  • P/E Ratio
  • BDRX N/A
  • FRES N/A
  • Revenue Growth
  • BDRX N/A
  • FRES N/A
  • 52 Week Low
  • BDRX $0.67
  • FRES $1.83
  • 52 Week High
  • BDRX $9.64
  • FRES $40.89
  • Technical
  • Relative Strength Index (RSI)
  • BDRX 41.69
  • FRES 30.45
  • Support Level
  • BDRX $0.91
  • FRES $2.56
  • Resistance Level
  • BDRX $1.20
  • FRES $2.68
  • Average True Range (ATR)
  • BDRX 0.14
  • FRES 0.38
  • MACD
  • BDRX -0.00
  • FRES -0.05
  • Stochastic Oscillator
  • BDRX 8.39
  • FRES 20.70

About BDRX Biodexa Pharmaceuticals plc American Depositary Shs

Biodexa Pharmaceuticals Plc is a drug delivery technology company focused on improving the bio-delivery and bio-distribution of medicines. The company combines approved and developed medications with its proprietary and innovative drug delivery technologies to provide compelling products that have the potential to powerfully impact the lives of patients.

About FRES Fresh2 Group Limited

Fresh2 Group Ltd is a biotechnology company. It focuses on early cancer screening and detection. The company markets and sells a multi-cancer screening and detection test that uses its innovative patented CDA technology and its proprietary CDA device. In addition to early cancer screening and detection, its CDA technology has demonstrated the potential to assist physicians in cancer diagnosis, prognosis, and recurrence.

Share on Social Networks: